Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 5 of 18

Comparative and Pragmatic Study of Simponi Aria Versus Remicade in Rheumatoid Arthritis

Inclusion Criteria: Patient must be a male or female 18 years of age or older as the study is intended to assess Golimumab intravenous (IV) and...

Kalpita Hatti, M.D.
  • Kadlec Clinic Rheumatology
  • Kadlec Research

A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis

Inclusion Criteria: Are ambulatory. Diagnosis of radiographic axial spondyloarthritis (rad-xSpA) with sacroiliitis defined radiographically...

Kalpita Hatti, M.D.
  • Kadlec Research

A Phase 3b/4 Randomized Double Blind Placebo Controlled Study Of Methotrexate (MTX) Withdrawal In Subjects With Rheumatoid Arthritis (RA) Treated With Tofacitinib 11mg Modified Release (MR) Formulation

This study is designed to evaluate the efficacy and safety of tofacitinib modified release formulation (11mg QD) versus tofacitinib modified...

Philip Mease, M.D.
  • Swedish Medical Center

A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis

Inclusion Criteria: Are ambulatory. Diagnosis of nonradiographic axial spondyloarthritis (nr-axSpA) and fulfilling the 2009 ASAS classification...

Kalpita Hatti, M.D.
  • Kadlec Research

SHS 280162 MEAP CELI 16059-A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis

The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying...

Philip Mease, M.D.
  • Swedish Medical Center
« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 5 of 18